Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
Mamaearth parent Honasa Consumer has acquired a 58% stake in Fluence Pharma, launching a new subsidiary Honasa Health under Dheeraj Nagpal to enter India's Rs 16,000 crore beauty-from-within nutraceuticals category alongside its existing Zingavita play.
What happened
Honasa Consumer, parent of Mamaearth, acquired a 58% stake in nutraceuticals firm Fluence Pharma to enter India's Rs 16,000 crore beauty-from-within segment via
Key facts
- 58% stake
- Rs 16,000 crore category size
Why this matters
A 58% structure with founder rollover is the playbook here, letting Honasa consolidate financials while keeping Fluence operators incentivized, and it sets a comp for nutraceutical deals in the Rs 16,000 cr beauty-from-within space.